Immunofluorescence in immunobullous diseases
Abstract
Immunofluorescence has become an essential component of today’s dermatological laboratory. During the last four decades, innovations in this field have revolutionized the concepts about the pathogenesis, diagnosis and differential diagnosis of autoimmune bullous diseases, hereditary bullous diseases, collagen-vascular diseases, many inflammatory dermatoses and cutaneous tumours. However, the facility is not widely available in Pakistan, and the physicians’ knowledge about this diagnostic tool is mostly theoretical. This review envisages the basics of immunofluorescence technique, the interpretation of the results and the newer advancements in the field which a physician is expected to know.References
Wojnarowska F, Eady RA, Burge SM. Bullous eruptions. In: Champion RH, Burton JL, Burns DA, Breathnach SM, eds. Textbook of Dermatology.6th edn. Oxford: Blackwell Science; 1998. p. 1817-98.
Kamarashev J. Immunohistochemical techniques for light microscopy. In: Kanitakis J, Vessileva S, Woodly D, eds. Diagnostic immunohistochemistry of the skin. 1st edn. London: Chapman and Hall Medical; 1998. p. 5-18.
Mustasim DF, Pelc NJ, Supapannachart N. Established methods in the investigation of bullous diseases. Dermatol Clin 1993; 11: 399-418.
Ueki H, Yaoita H, eds. A Color Atlas of Dermato-immunohistocytology. 1st edn. Tokyo: Wolfe Medical Publications; 1989.
Holubar K. Autoimmune skin diseases since 1963. Dermatology 1994; 189 (Suppl 1): 3-5.
Kirtsching G, Wojnarowska F. Autoimmune blistering diseases: An update of diagnostic methods and investigations. Clin Exp Dermatol 1994; 19: 97-112.
Valenzuela R, Bergfeld WF, Deodhar SD, eds. Interpretation of immunofluorescent patterns in skin diseases. 1st edn. Chicago: American Society of Clinical Pathologists Press; 1984.
Vassileva S. Immunofluorescence in dermatology. Int J Dermatol 1993; 32: 153-61.
Feliciani C, DiMuzio M, Mohammad-Pour S et al. ‘Suction-split’ as a routine method to differentiate epidermolysis bullosa acquisita from bullous pemphigoid. J Eur Acad Dermatol Venereol 1998; 10: 243-7.
Bhogal BS, Black MM. Diagnosis, diagnostic and research techniques. In: Wojnarowska F, Briggaman RA, eds. Management of blistering diseases. 1st edn. London: Chapman and Hall Medical; 1990. p. 15-34.
Nousari HC, Anhalt GH. Pemphigus vulgaris, paraneoplastic pemphigus and pemphigus foliaceus. In: Kanitakis J, Vassileva S, Woodly D, eds. Diagnostic immunohistochemistry of the skin, 1st edn. London: Chapman and Hall Medical; 1998. p. 79-83.
Ratnam KV, Rang BK. Pemphigus in remission: value of negative direct immunofluorescence in management. J Am Acad Dermatol 1994; 30: 547-50
Iwatsuki K. IgA pemphigus. In: Kanitakis J, Vassileva S, Woodly D, eds. Diagnostic immunohistochemistry of skin. 1st edn. London: Chapman and Hall Medical; 1998. p. 95-104.
Weigand DA, Clements MK. Direct immunofluorescence in bullous pemphigoid: effect of extent and location of lesions. J Am Acad Dermatol 1989; 20: 437-40.
Anstey A, Venning V, Wojnarowska F et al. Determination of the optimum site for diagnostic biopsy for direct immunofluorescence in bullous pemphigoid. Clin Exp Dermatol 1990; 15: 438-41.
Hsu S, Ghohestani RF, Uitto J. Lichen planus pemphigoides with IgG autoantibodies to 180 kd bullous pemphigoid antigen (type XVII) collagen. J Am Acad Dermatol 2000; 42: 136-41.
Skaria M, Salomon D, Jaunin F et al. IgG autoantibodies from a lichen planus pemphigoides patient recognize the NC16A domain of the bullous pemphigoid antigen 180. Dermatology 1999; 199: 253-5.
Katz SI. Herpes gestationis (pemphigoid gestationis). Freedberg IM, Eisen AZ, Wolff K et al., eds. Dermatology in general medicine. 5th edn. New York: McGraw-Hill; 1998. p. 686-9.
Gammon WR, Fine JD, Forbes M, Briggaman RA. Immunofluorescence on salt-split skin for the detection and differentiation of basement membrane zone autoantibodies. J Am Acad Dermatol 1992; 27: 79-87.
Smoller BR, Woodley DT. Differences in direct immunofluorescence staining patterns in epidermolysis bullosa acquisita and bullous pemphigoid. J Am Acad Dermatol 1992; 27: 674-8.
Hultsch ND, Bisalbutra P, Gammon WR, Yancey KB. Direct immunofluorescence microscopy on 1 mol/L sodium chloride-treated patient skin. J Am Acad Dermatol 1991; 24: 946-51.
de Jong MC, Bruins S, Heeres K et al. Bullous pemphigoid and epidermolysis bullosa acquisita: differentiation by fluorescent overlay antigen mapping. Arch Dermatol 1996; 132: 151-7.
Banfield CC, Allen J, Wojnarowska FT. Dermatitis herpetiformis and linear IgA disease. In: Kanitakis J, Vessileva S, Woodley D, eds. Diagnostic immunohistochemistry of the skin. 1st edn. London: Chapman and Hall Medical; 1998. p. 105-13.
Zone JJ, Meyer LT, Petersen MJ. Deposition of granular IgA relative to clinical lesions of dermatitis herpetiformis. Arch Dermatol 1996; 132: 912-8.
Pas HH, de Jong MC, Jonckman MF et al. Bullous pemphigoid antibody titre and antigen specificity. Exp Dermatol 1995; 4: 372-6.
Schmidt E, Obe K, Brocker EB, Zillikens D. Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid. Arch Dermatol 2000; 136: 174-8.
Mustasim DE. The accuracy of indirect immunofluorescence on sodium chloride-split skin in differentiating subepidermal bullous diseases. Arch Dermatol 1997; 133: 1158-60.
Egan CA, Martineau MR, Taylor TB et al. IgA antibodies recognizing LABD97 are predominantly IgA1 subclass. Acta Derm Venereol 1999; 79: 343-6.
Guidice GJ, Diaz LA. New laboratory methods in the investigation of bullous disease. Dermatol Clin 1993; 11: 419-27.
Lenz P, Amagai M, Platzer BV et al. Desmoglein 3 ELISA: a pemphigus vulgaris-specific diagnostic tool. Arch Dermatol 1999; 135: 143-8.
Nishikawa T. Desmoglein ELISAs: a novel diagnostic tool for pemphigus. Arch Dermatol 1999; 135: 195-7.
Mustasim DF, Vaughan A, Supapannachart N, Farooqui J. Skin explant culture: a reliable method for detecting pemphigoid antibodies in pemphigoid sera by standard immunofluorescence and immunoblotting. J Invest Dermatol 1993; 101: 624-7.
